Your browser doesn't support javascript.
loading
The Choice Between Advanced Therapies for Parkinson's Disease Patients: Why, What, and When?
Dijk, Joke M; Espay, Alberto J; Katzenschlager, Regina; de Bie, Rob M A.
Afiliação
  • Dijk JM; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands.
  • Espay AJ; Department of Neurology, James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, University of Cincinnati, Cincinnati, OH, USA.
  • Katzenschlager R; Donauspital, Department of Neurology and Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Vienna, Austria.
  • de Bie RMA; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands.
J Parkinsons Dis ; 10(s1): S65-S73, 2020.
Article em En | MEDLINE | ID: mdl-32651333
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Apomorfina / Carbidopa / Levodopa / Estimulação Encefálica Profunda / Antiparkinsonianos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Apomorfina / Carbidopa / Levodopa / Estimulação Encefálica Profunda / Antiparkinsonianos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article